Xavier Soler

4.5k total citations
66 papers, 1.5k citations indexed

About

Xavier Soler is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Xavier Soler has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Physiology, 33 papers in Pulmonary and Respiratory Medicine and 12 papers in Immunology. Recurrent topics in Xavier Soler's work include Asthma and respiratory diseases (28 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (23 papers) and IL-33, ST2, and ILC Pathways (11 papers). Xavier Soler is often cited by papers focused on Asthma and respiratory diseases (28 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (23 papers) and IL-33, ST2, and ILC Pathways (11 papers). Xavier Soler collaborates with scholars based in United States, Spain and France. Xavier Soler's co-authors include Andrew L. Ries, José S. Loredo, Atul Malhotra, Joe Ramsdell, Timothy A. Morris, James J. Marsh, Chad Cook, Larissa Braga, Ricardo Pietrobon and Lawrence A. Palinkas and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Xavier Soler

58 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Soler United States 19 683 592 253 212 167 66 1.5k
Ben Brumpton Norway 22 476 0.7× 640 1.1× 73 0.3× 106 0.5× 28 0.2× 94 1.7k
Renée de Mutsert Netherlands 25 225 0.3× 466 0.8× 78 0.3× 120 0.6× 173 1.0× 65 2.3k
Daniel Norman United States 20 480 0.7× 557 0.9× 373 1.5× 284 1.3× 37 0.2× 38 1.5k
Alfredo De Giorgi Italy 24 159 0.2× 169 0.3× 282 1.1× 277 1.3× 40 0.2× 126 1.7k
Avery Tung United States 30 312 0.5× 134 0.2× 160 0.6× 163 0.8× 69 0.4× 127 2.5k
Hans Åberg Sweden 21 136 0.2× 364 0.6× 127 0.5× 65 0.3× 113 0.7× 66 1.6k
Huiyong Zheng United States 24 63 0.1× 349 0.6× 193 0.8× 282 1.3× 29 0.2× 55 2.2k
Maria E. Czira Hungary 25 183 0.3× 300 0.5× 124 0.5× 253 1.2× 22 0.1× 39 1.6k
Robert Walter United States 8 762 1.1× 582 1.0× 187 0.7× 137 0.6× 24 0.1× 19 1.3k
Anna Fry United Kingdom 7 123 0.2× 457 0.8× 49 0.2× 154 0.7× 48 0.3× 11 2.5k

Countries citing papers authored by Xavier Soler

Since Specialization
Citations

This map shows the geographic impact of Xavier Soler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Soler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Soler more than expected).

Fields of papers citing papers by Xavier Soler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Soler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Soler. The network helps show where Xavier Soler may publish in the future.

Co-authorship network of co-authors of Xavier Soler

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Soler. A scholar is included among the top collaborators of Xavier Soler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Soler. Xavier Soler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porsbjerg, Celeste, Eleanor M. Dunican, Njira Lugogo, et al.. (2025). Effect of dupilumab on mucus burden in patients with moderate-to-severe asthma: the VESTIGE trial. American Journal of Respiratory and Critical Care Medicine. 212(2). 241–252.
2.
Lommatzsch, Marek, Stephanie Korn, Olaf Schmidt, et al.. (2025). Real-world outcomes after 2 years of dupilumab therapy for severe asthma: the ProVENT study. PA477–PA477.
3.
Celli, Bartolomé R., Klaus F. Rabe, Maarten van den Berge, et al.. (2025). Current Smoker: A Clinical Chronic Obstructive Pulmonary Disease Phenotype Affecting Disease Progression and Response to Therapy. American Journal of Respiratory and Critical Care Medicine. 211(5). 729–736. 5 indexed citations
4.
Heffler, Enrico, Vicente Plaza, Ole Hilberg, et al.. (2024). Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry. Journal of Asthma and Allergy. Volume 17. 551–556. 1 indexed citations
5.
6.
Wechsler, Michael E., Linda Rogers, Giorgio Walter Canonica, et al.. (2024). Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics. ERJ Open Research. 10(6). 188–2024.
7.
Bleecker, Eugene R., Michael S. Blaiss, Juby A. Jacob‐Nara, et al.. (2024). Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic corticosteroid prescriptions: Real-world US ADVANTAGE study. Journal of Allergy and Clinical Immunology. 154(6). 1500–1510. 9 indexed citations
8.
Máspero, Jorge, Shirin Shafazand, Jeremy Cole, et al.. (2023). Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma. Respiratory Medicine. 218. 107344–107344. 2 indexed citations
9.
Corren, Jonathan, Nicola A. Hanania, William W. Busse, et al.. (2023). Efficacy of dupilumab in patients with uncontrolled, moderate‐to‐severe asthma with fungal sensitization. Clinical & Experimental Allergy. 53(10). 1020–1030. 3 indexed citations
10.
Blaiss, Michael S., Eugene R. Bleecker, Juby A. Jacob‐Nara, et al.. (2023). Real-world effectiveness of dupilumab in patients with asthma. Annals of Allergy Asthma & Immunology. 132(4). 463–468.e1. 10 indexed citations
11.
Hanania, Nicola A., Mario Castro, Eric D. Bateman, et al.. (2022). Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction. Annals of Allergy Asthma & Immunology. 130(2). 206–214.e2. 8 indexed citations
12.
Regan, Elizabeth A., Barry J. Make, MeiLan K. Han, et al.. (2022). Clinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals With Smoking Exposure. CHEST Journal. 163(2). 292–302. 3 indexed citations
13.
Ruíz, Pablo, et al.. (2020). Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience. Medicina Clínica (English Edition). 155(9). 410–411. 2 indexed citations
14.
Blackford, Amanda L., Matthew R. Lammi, Anne L. Fuhlbrigge, et al.. (2018). Clinical Differences in COPD Patients with Variable Patterns of Hypoxemia. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 5(3). 167–176. 3 indexed citations
15.
Full, Kelsie M, Jacqueline Kerr, Michael A. Grandner, et al.. (2018). Validation of a physical activity accelerometer device worn on the hip and wrist against polysomnography. Sleep Health. 4(2). 209–216. 83 indexed citations
16.
Krachman, Samuel L., Daohai Yu, Xavier Soler, et al.. (2016). Effect of Emphysema Severity on the Apnea–Hypopnea Index in Smokers with Obstructive Sleep Apnea. Annals of the American Thoracic Society. 13(7). 1129–1135. 56 indexed citations
17.
Soler, Xavier, Frank L. Powell, Joe Ramsdell, et al.. (2015). High Prevalence of Obstructive Sleep Apnea in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 12(8). 1219–1225. 139 indexed citations
18.
Morris, Timothy A., James J. Marsh, Peter G. Chiles, et al.. (2009). High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood. 114(9). 1929–1936. 120 indexed citations
19.
Soler, Xavier, Rebecca Sell, José M. Maestre, & Juan Ruiz-Manzano. (2009). Bronchial Rupture by an Unusual Mechanism of Thoracic Hyperextension. Journal of Emergency Medicine. 42(5). 535–537. 2 indexed citations
20.
Panés, Julián, Joan Caballería, Raimón Guitart, et al.. (1993). Determinants of Ethanol and Acetaldehyde Metabolism in Chronic Alcoholics. Alcoholism Clinical and Experimental Research. 17(1). 48–53. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ben Brumpton Breakdown of academic impact, for papers by Renée de Mutsert Breakdown of academic impact, for papers by Daniel Norman Breakdown of academic impact, for papers by Alfredo De Giorgi Breakdown of academic impact, for papers by Avery Tung Breakdown of academic impact, for papers by Hans Åberg Breakdown of academic impact, for papers by Huiyong Zheng Breakdown of academic impact, for papers by Maria E. Czira Breakdown of academic impact, for papers by Robert Walter Breakdown of academic impact, for papers by Anna Fry
Rankless by CCL
2026